Skip to content
24/7 Support
Save up to 80%
Fast & Discrete Delivery
Glucophage

Glucophage

Quality products
24/7 Support
Fast delivery
Delivery from 4 days
Active ingredient Metformin

Free delivery on orders from AED 796.00, free express delivery from AED 1,194.00

Glucophage is an oral antidiabetic medicine for adults with type 2 diabetes. Its active ingredient, metformin, lowers excess glucose production and helps the body respond more effectively to insulin.

Description

It contains metformin, a biguanide that reduces excess glucose production by the liver and improves the body’s response to insulin. This supports better blood glucose and HbA1c control with a low risk of hypoglycaemia when used alone.

Composition

Glucophage contains metformin hydrochloride, the active substance responsible for its blood-glucose-lowering action. Metformin belongs to the biguanide class of oral antidiabetic agents and is used mainly in type 2 diabetes mellitus.

The medicine works without directly forcing the pancreas to release more insulin. This explains why metformin alone has a low risk of hypoglycaemia compared with medicines that stimulate insulin secretion.

Glucophage tablets are taken by mouth. The prescribed strength and daily schedule depend on blood glucose results, kidney function, tolerance, age, and other diabetes treatments.

Metformin may be prescribed as:

  • Initial treatment for adults with newly diagnosed type 2 diabetes.
  • Ongoing treatment when diet and physical activity do not provide adequate control.
  • Combination treatment with other oral antidiabetic medicines or insulin.
  • Treatment for people who need improved insulin sensitivity.
  • Selected metabolic indications under specialist supervision.

The immediate-release form may require divided doses with meals. Modified-release metformin products use a different release pattern and must be prescribed as a specific formulation rather than substituted casually.

Taking metformin with a meal can reduce stomach upset. The tablet should be swallowed exactly as prescribed; modified-release tablets must not be crushed or chewed because this can change how the dose is released.

Dosage and usage

Glucophage is taken by mouth as an oral antidiabetic medicine for adults with type 2 diabetes. Its active ingredient, metformin, reduces excess glucose production by the liver and improves the body's response to insulin, supporting better blood glucose and HbA1c control with a low risk of hypoglycaemia when used alone. Treatment works best alongside an individualised eating plan, regular movement and blood glucose monitoring.

How it works

Metformin reduces excess glucose production by the liver and improves the body’s response to insulin. These effects increase the effectiveness of the body’s existing insulin response and support lower blood glucose and HbA1c levels. When used alone, its glucose-lowering action has a low risk of hypoglycaemia.

Indications

Glucophage is used primarily to manage type 2 diabetes mellitus. It lowers elevated blood glucose while supporting the body’s existing insulin response. The treatment works best alongside an individualised eating plan, regular movement, and blood glucose monitoring.

Type 2 diabetes develops when the body becomes less responsive to insulin and the liver releases more glucose than needed. Metformin addresses both processes. It is frequently selected as a first-line medicine because it has a long clinical history, does not usually cause weight gain, and rarely causes hypoglycaemia when taken without other glucose-lowering drugs [1].

Prediabetes is a state in which blood glucose is above the normal range but below the diagnostic threshold for diabetes. Metformin may be considered for selected people with prediabetes, especially where the risk of progression is high. This decision depends on factors such as body weight, age, previous gestational diabetes, fasting glucose, HbA1c, and lifestyle response.

Polycystic ovarian syndrome can involve insulin resistance and irregular ovulation. Metformin is sometimes used in this setting under medical supervision, especially when impaired glucose regulation is present. It is not a universal treatment for every symptom of polycystic ovarian syndrome.

Comparison

Glucophage occupies a different pharmacological position from other diabetes treatments. The appropriate choice depends on cardiovascular disease, kidney function, heart failure, weight goals, hypoglycaemia risk, and treatment response.

Drug class Main action and typical clinical consideration
Biguanide Reduces hepatic glucose production and improves insulin sensitivity; low hypoglycaemia risk alone, with gastrointestinal effects possible
Sulfonylurea Increases pancreatic insulin release; can lower glucose effectively but carries a higher hypoglycaemia and weight-gain risk
SGLT2 inhibitor Increases urinary glucose excretion; may provide kidney or heart benefits in selected patients, with genital and urinary adverse effects possible
DPP-4 inhibitor Prolongs incretin activity; generally weight-neutral with a low hypoglycaemia risk when used alone
GLP-1 receptor agonist Enhances glucose-dependent insulin release and reduces appetite; may support weight reduction but can cause gastrointestinal symptoms
Insulin Directly replaces or supplements insulin; highly effective but requires careful dose adjustment and carries hypoglycaemia risk

Metformin is often retained when another medicine is added, provided it remains tolerated and kidney function permits continued use. The World Health Organization includes metformin among established medicines for type 2 diabetes management [2].

Contraindications

Specific situations requiring medical review include:

  • Reduced kidney function or rapidly changing kidney function.
  • Severe dehydration.
  • Serious infection or circulatory collapse.
  • Acute heart failure or conditions associated with low oxygen.
  • Severe liver disease.
  • Heavy alcohol intake.
  • Planned surgery involving prolonged fasting.
  • An investigation using iodinated contrast media.
  • Pregnancy or breastfeeding, where diabetes treatment requires individual assessment.

Kidney function is central to safe prescribing because metformin is cleared mainly through the kidneys. Older adults and people with chronic kidney disease may need more frequent renal monitoring.

Iodinated contrast procedures can temporarily affect kidney function. The diabetes treatment plan may need adjustment before or after contrast exposure, depending on renal function and the procedure.

Some medicines can raise the risk of complications or change blood glucose control. These include diuretics, corticosteroids, medicines affecting kidney function, certain blood-pressure treatments, and other antidiabetic agents. Alcohol can increase metabolic risk, especially when intake is heavy or combined with poor food intake.

Tell the clinician arranging an X-ray or scan that you take metformin before iodinated contrast is administered. The timing of treatment may need to change even when you feel well.

When this is not for you

Talk to a clinician before using Glucophage if you have kidney or liver problems, severe dehydration, a serious infection, heart or breathing problems, drink heavily, are planning surgery, or are having an X-ray or scan with contrast. Pregnancy and breastfeeding also require an individual treatment review.

Side effects

The most common adverse effects involve the digestive system. They include nausea, loose stools, diarrhoea, abdominal discomfort, bloating, and reduced appetite. These effects are more likely when treatment begins or when the dose increases quickly.

Taking Glucophage with food can improve tolerance. A gradual dose increase may also help. Some patients who cannot tolerate immediate-release metformin are prescribed a modified-release formulation, though the choice must be made by the prescriber.

Metformin alone rarely causes hypoglycaemia because it does not normally increase insulin secretion. The risk rises when it is combined with insulin or medicines that stimulate insulin release. Alcohol, missed meals, prolonged fasting, and strenuous exercise can further complicate glucose control.

Long-term metformin treatment may reduce vitamin B12 absorption in some patients. Symptoms such as persistent tiredness, numbness, pins and needles, a sore tongue, or unusual weakness may require a B12 blood test.

Lactic acidosis is a rare but serious reaction associated with metformin accumulation. The risk is higher with severe kidney impairment, severe dehydration, conditions causing low oxygen levels, serious infection, heavy alcohol exposure, or acute heart or respiratory failure. Symptoms requiring urgent assessment include marked weakness, rapid or difficult breathing, persistent vomiting, abdominal pain, unusual sleepiness, and feeling cold.

Severe diarrhoea, vomiting, fever, or poor fluid intake can temporarily increase metformin-related risk because dehydration reduces kidney function. A clinician may advise a temporary pause until normal hydration and kidney function are restored.

Common mistakes

Several avoidable mistakes reduce tolerability or make glucose results difficult to interpret:

  • Taking the tablet on an empty stomach despite repeated digestive symptoms.
  • Doubling the next dose after a missed tablet.
  • Crushing a modified-release tablet.
  • Stopping treatment abruptly without a plan when glucose readings improve.
  • Continuing the usual dose during severe vomiting or dehydration without obtaining clinical guidance.
  • Forgetting to mention metformin before iodinated contrast imaging.
  • Assuming that diarrhoea is harmless when it is severe or accompanied by weakness and poor fluid intake.
  • Drinking heavily while eating very little.
  • Treating one high glucose reading as proof that the medicine has failed.
  • Failing to report numbness, persistent fatigue, or other symptoms that could suggest vitamin B12 deficiency.

A missed dose is generally handled by taking the next scheduled dose rather than taking extra tablets. The exact instruction depends on the prescribed regimen.

What doctors say

In clinical practice, doctors often focus first on tolerance, kidney function, and realistic glucose targets rather than expecting an immediate dramatic change. A patient who takes the medicine consistently but develops persistent diarrhoea may need a slower titration or a different release formulation.

A physician also assesses the whole treatment pattern. HbA1c may remain high because of missed doses, steroid treatment, infection, sleep disruption, or progression of insulin deficiency. Increasing metformin without identifying the cause may not solve the problem.

Another practical point is that metformin supports diabetes control but does not remove the need for nutrition planning, movement, or monitoring. Its benefits are usually maintained through regular use rather than occasional dosing.

The NICE guideline for type 2 diabetes supports structured treatment adjustment based on HbA1c, comorbidities, adverse effects, and patient circumstances [3].

Frequently asked questions

What is Glucophage used for?

Glucophage is used mainly for type 2 diabetes mellitus in adults. It contains metformin, which reduces liver glucose production and improves insulin sensitivity. The FDA's 2023 prescribing information describes metformin as an oral treatment used with diet and physical activity to improve glycaemic control [4]. Treatment for prediabetes or polycystic ovarian syndrome may be considered in selected cases.

Does Glucophage cause low blood sugar?

Metformin alone has a low risk of hypoglycaemia because it does not usually stimulate insulin release. The risk can increase when it is combined with insulin or an insulin-releasing medicine. The WHO’s 2019 diabetes guidance supports considering the complete treatment combination when assessing hypoglycaemia risk. Symptoms such as sweating, shaking, confusion, or sudden weakness require prompt attention.

How long does Glucophage take to work?

Metformin begins affecting glucose handling after treatment starts, but HbA1c changes require several weeks to become measurable. A full assessment commonly uses repeated blood glucose readings and follow-up HbA1c testing. NICE guidance published in 2022 recommends reviewing treatment according to glucose response, tolerance, and individual targets. A single reading cannot establish the full treatment effect.

Can Glucophage be taken with food?

Taking immediate-release metformin with food often reduces nausea, abdominal discomfort, and diarrhoea. The timing should match the prescribed schedule, since different formulations release metformin differently. The EMA's 2024 product information for metformin-containing medicines describes administration with meals as part of gastrointestinal tolerability management. Alcohol intake should remain limited because heavy use can increase metabolic risk.

Is Glucophage suitable for people with kidney disease?

Kidney function determines whether metformin can be started, continued, or adjusted. Severe renal impairment is a contraindication, and changing kidney function may require prompt treatment review. FDA safety information from 2016 links metformin use with renal-function assessment before and during therapy. Dehydration, severe infection, and contrast procedures can temporarily increase concern even in someone whose previous kidney tests were satisfactory.

Can Glucophage help with polycystic ovarian syndrome?

Metformin may be used in selected people with polycystic ovarian syndrome when insulin resistance or impaired glucose regulation is present. It may support metabolic measures, but it is not suitable for every symptom or every patient. The 2023 international evidence-based guideline developed with Monash University for polycystic ovarian syndrome places treatment choice within the person’s metabolic profile and reproductive goals. Pregnancy planning requires an individual treatment review.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Comparison

Glucophage: Reviews and Experiences

4.3
Based on 4 reviews
Samir, 52
Abu Dhabi
Several weeks
Verified
Rating: 4 out of 5

The first ten days were uncomfortable because of loose stools after breakfast. Taking it with my main meal helped. My readings became steadier after several weeks, but I still needed to change my evening eating habits.

5 Nov 2026
Mariam, 46
Dubai
Long-term
Verified
Rating: 3.5 out of 5

I had used the tablets alone for a long time without low readings. After another medicine was added, I had two episodes of shakiness before meals and had to review the full regimen.

10 Oct 2026
Omar, 61
Sharjah
Long-term
Verified
Rating: 5 out of 5

The medicine itself was manageable. My main problem was forgetting it when my routine changed during travel. A written dosing schedule helped me avoid missed tablets.

16 Oct 2026
Lina, 39
Al Ain
Several weeks
Verified
Rating: 4.5 out of 5

Stomach symptoms improved after the dose was increased more gradually. I did not notice an immediate change, but later blood tests showed better glucose control.

26 Oct 2026

Sources

  1. U.S. Food and Drug Administration (2023). Glucophage (metformin hydrochloride) tablets prescribing information.
  2. World Health Organization (2019). WHO Model List of Essential Medicines, 21st list.
  3. National Institute for Health and Care Excellence (2022). Type 2 diabetes in adults: management, NICE guideline NG28.
  4. U.S. Food and Drug Administration (2016). Drug Safety Communication: FDA revises warnings regarding use of metformin in certain patients with reduced kidney function.
Get our free app Shop faster and track your orders 4.1 · 499 reviews Install